Zdrowie i gospodarka · 25/07/2017

FDA Publishes Revised Guidance on Benefit-Risk Information for Regulatory Submissions

The FDA has released a revised guidance on presenting benefit-risk information in regulatory submissions, developed in collaboration with the International Council for Harmonisation, to enhance communication between regulators and industry.